Literature DB >> 29931556

Acute Coronary Syndrome in Cancer Patients.

Begum Yetis Sayin1, Mehmet Ali Oto2.   

Abstract

Cardiologists are seeing an increasing number of oncology patients every day, and acute coronary syndrome (ACS) is one of the problems patients encounter during follow-up. Cardio-oncology is the care of patients with cancer and cardiovascular disease, whether overt or occult, already established or acquired during treatment. Cardiovascular complications can occur acutely during or shortly after treatment and persist as long-term effects for months to years after treatment. As a delayed effect of cancer treatment, cardiovascular damage can occur months to years after the initial treatment. Vasospasm, thrombosis, and radiation-induced cardiovascular diseases can all cause ACS. Careful surveillance of ACS symptoms and regular screening during follow-up of patients with malignancy are suggested. In this review, we summarize the ACS we usually encounter during a range of cancer treatments or post cancer survival by providing illustrative case examples.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29931556     DOI: 10.1007/s40256-018-0286-z

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN: 1175-3277            Impact factor:   3.571


  3 in total

Review 1.  Chest Pain in the Cancer Patient.

Authors:  Sara Tyebally; Aruni Ghose; Daniel H Chen; Aderonke T Abiodun; Arjun K Ghosh
Journal:  Eur Cardiol       Date:  2022-05-31

Review 2.  Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity.

Authors:  Lars Michel; Tienush Rassaf; Matthias Totzeck
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 3.  Challenges and Management of Acute Coronary Syndrome in Cancer Patients.

Authors:  Isabela Bispo Santos da Silva Costa; Fernanda Thereza de Almeida Andrade; Diego Carter; Vinicius B Seleme; Maycon Santos Costa; Carlos M Campos; Ludhmila Abrahão Hajjar
Journal:  Front Cardiovasc Med       Date:  2021-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.